Ionis Pharmaceuticals is conducting a Phase 2b trial of fesomersen, an investigational antisense drug designed to reduce the …
Tag:
Ionis
-
-
Medicine
Ionis provides update on development program evaluating PCSK9 antisense medicine for the treatment of hypercholesterolemia
ION449 (AZD8233) met phase primary endpoint 2b Solano Studies for patients with hypercholesterolemia ION449 will not proceed to …